Skip to main content

Garrison Point Advisors, LLC

SEC CIK
0001767107
Latest filing
Jul 31, 2026

ACAD holding history

Acadia Pharmaceuticals Inc in every 13F filed by Garrison Point Advisors, LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

ACAD overviewAll 13F holders of ACADFull Q2 2026 holdings

Shares (Q2 2026)
9,501
Value
$240.4K
% of portfolio
0.1%
Quarters held
18
Since Q4 2021
Holdings of ACAD by Garrison Point Advisors, LLC, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 20269,501$240.4K0.1%00.0%UnchangedHolders
Q1 20269,501$211.5K0.1%00.0%UnchangedHolders
Q4 20259,501$253.8K0.1%−1,075−10.2%ReducedHolders
Q3 202510,576$225.7K0.1%00.0%UnchangedHolders
Q2 202510,576$228.1K0.1%00.0%UnchangedHolders
Q1 202510,576$175.7K0.1%00.0%UnchangedHolders
Q4 202410,576$194.1K0.1%00.0%UnchangedHolders
Q3 202410,576$162.7K0.1%+10,576NewHolders
Q2 20240$00.0%−10,020−100.0%Sold outHolders
Q1 202410,020$185.3K0.1%00.0%UnchangedHolders
Q4 202310,020$313.7K0.2%00.0%UnchangedHolders
Q3 202310,020$208.8K0.2%00.0%UnchangedHolders
Q2 202310,020$240.0K0.2%−250−2.4%ReducedHolders
Q1 202310,270$193.3K0.1%00.0%UnchangedHolders
Q4 202210,270$163.5K0.1%00.0%UnchangedHolders
Q3 202210,270$168.0K0.1%00.0%UnchangedHolders
Q2 202210,270$145.0K0.1%+50+0.5%AddedHolders
Q1 202210,220$248.0K0.2%00.0%UnchangedHolders
Q4 202110,220$239.0K0.2%+10,220NewHolders